ABRAXIS BIOSCIENCE Trademark

Trademark Overview

On Friday, January 27, 2006, a trademark application was filed for ABRAXIS BIOSCIENCE with the United States Patent and Trademark Office. The USPTO has given the ABRAXIS BIOSCIENCE trademark a serial number of 78800790. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, March 14, 2019. This trademark is owned by American Pharmaceutical Partners, Inc.. The ABRAXIS BIOSCIENCE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals, namely, oncolytics; pharmaceuticals for the treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery system composed of nanoparticles sold as an integral component of drugs

[ Medical information services ]

Research and development in the field of pharmaceuticals and drug delivery
abraxis bioscience

General Information

Serial Number78800790
Word MarkABRAXIS BIOSCIENCE
Filing DateFriday, January 27, 2006
Status800 - REGISTERED AND RENEWED
Status DateThursday, March 14, 2019
Registration Number3747838
Registration DateTuesday, February 9, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2006

Trademark Statements

Goods and ServicesPharmaceuticals, namely, oncolytics; pharmaceuticals for the treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery system composed of nanoparticles sold as an integral component of drugs
Goods and Services[ Medical information services ]
Disclaimer with Predetermined Text"BIOSCIENCE"
Goods and ServicesResearch and development in the field of pharmaceuticals and drug delivery

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 2, 2006
Primary Code005
First Use Anywhere DateWednesday, November 30, 2005
First Use In Commerce DateFriday, February 29, 2008
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 2, 2006
Primary Code042
First Use Anywhere DateWednesday, November 30, 2005
First Use In Commerce DateWednesday, November 30, 2005
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateThursday, March 14, 2019
Primary Code044
First Use Anywhere DateWednesday, November 30, 2005
First Use In Commerce DateWednesday, November 30, 2005

Trademark Owner History

Party NameABRAXIS BIOSCIENCE, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSummit, NJ 07901
Party NameABRAXIS BIOSCIENCE, LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressLOS ANGELES, CA 90025
Party NameABRAXIS BIOSCIENCE, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLOS ANGELES, CA 90025
Party NameAmerican Pharmaceutical Partners, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSchaumburg, IL 601735837
Party NameAmerican Pharmaceutical Partners, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSchaumburg, IL 601735837

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 14, 2019NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, March 14, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, March 14, 2019REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Thursday, March 14, 2019REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Thursday, March 14, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 11, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, February 9, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, January 25, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 25, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, February 22, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, February 22, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, February 22, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 9, 2015TEAS SECTION 8 & 15 RECEIVED
Monday, February 9, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 15, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 15, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 9, 2010REGISTERED-PRINCIPAL REGISTER
Monday, January 4, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Sunday, January 3, 2010ASSIGNED TO LIE
Monday, December 14, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 13, 2009STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 11, 2009USE AMENDMENT FILED
Wednesday, November 11, 2009TEAS STATEMENT OF USE RECEIVED
Friday, June 26, 2009SOU EXTENSION 5 GRANTED
Thursday, June 4, 2009SOU EXTENSION 5 FILED
Friday, June 26, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 4, 2009TEAS EXTENSION RECEIVED
Tuesday, October 28, 2008SOU EXTENSION 4 GRANTED
Tuesday, October 28, 2008SOU EXTENSION 4 FILED
Tuesday, October 28, 2008TEAS EXTENSION RECEIVED
Wednesday, May 28, 2008SOU EXTENSION 3 GRANTED
Thursday, May 15, 2008SOU EXTENSION 3 FILED
Thursday, May 15, 2008TEAS EXTENSION RECEIVED
Wednesday, December 5, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 3, 2007SOU EXTENSION 2 GRANTED
Tuesday, November 20, 2007SOU EXTENSION 2 FILED
Tuesday, November 27, 2007TEAS EXTENSION RECEIVED
Thursday, August 30, 2007REVIEW OF CORRESPONDENCE COMPLETE
Thursday, May 17, 2007TEAS EXTENSION RECEIVED
Thursday, May 17, 2007FAX RECEIVED
Wednesday, May 16, 2007SOU EXTENSION 1 GRANTED
Wednesday, May 16, 2007SOU EXTENSION 1 FILED
Wednesday, May 16, 2007TEAS EXTENSION RECEIVED
Tuesday, December 5, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2006NOTICE OF PUBLICATION
Tuesday, July 25, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 25, 2006ASSIGNED TO LIE
Saturday, July 1, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 1, 2006EXAMINER'S AMENDMENT ENTERED
Saturday, July 1, 2006EXAMINERS AMENDMENT E-MAILED
Saturday, July 1, 2006EXAMINERS AMENDMENT -WRITTEN
Saturday, July 1, 2006AMENDMENT FROM APPLICANT ENTERED
Friday, June 23, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 23, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 21, 2006COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Tuesday, June 20, 2006ASSIGNED TO LIE
Monday, June 19, 2006EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, June 19, 2006EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, June 13, 2006ASSIGNED TO EXAMINER
Wednesday, June 7, 2006ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, February 2, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

bioscience abraxis pharmaceuticals drug delivery component drugs integral medical development field research